Remove tag company-profile
article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Antibody 130
article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

The US Food and Drug Administration (FDA) put a high-profile bluebird bio trial for sickle cell disease on partial clinical hold, and advisory panels deliberated over decisions involving gene therapies for amyotrophic lateral sclerosis (ALS), cerebral adrenoleukodystrophy (CALD), and beta-thalassemia.

Drugs 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Are RXBars Healthy? An In-Depth Look at the Trending Protein Bar

XTalks

The brand’s popularity reached new heights when Kellogg’s acquired the company for an impressive $600 million in 2017. So, what justifies such a hefty price tag and are RXBars healthy? A Protein Bar’s Ideal Nutritional Profile Not all protein bars are created equal in terms of their nutritional profile and ingredients.

Protein 59
article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

Some of them could be internal (CRM data and physicians profiling, etc.) Importantly, these materials do not need to originate solely from pharmaceutical companies but can also come from external sources. but others must be external such as: electronic health records, prescription data, medical literature, social media, and more.

article thumbnail

Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates

The Pharma Data

Joshua Liang, Chief Executive Officer of Clover Biopharmaceuticals, said, “With positive results from our Phase 1 clinical trial demonstrating strong neutralizing immune responses and favorable safety profiles, we look forward to moving our COVID-19 vaccines into the final stages of clinical development. About Trimer-Tag © Technology.

article thumbnail

Almirall and IRB Barcelona team up to tackle skin disease

pharmaphorum

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. However, states the company, many of these potentially therapeutically relevant proteins are “not amenable to conventional small-molecule inhibitors, as they lack defined ligand-binding pockets”.

article thumbnail

bluebird bio to split into oncology and gene therapy specialists

pharmaphorum

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. Meanwhile the as-yet unnamed oncology company will spin off under the leadership of bluebird’s current chief executive Nick Leschly. million price tag.